Literature DB >> 11215487

[Pathological, cytological and immunohistochemical study of normal-sized ovary carcinoma syndrome].

Y Takekawa1, M Kimura, M Sakakibara, R Yoshii, T Shikata.   

Abstract

Normal-sized ovary carcinoma syndrome(NOCS) is characterized by diffuse metastatic malignant disease of the abdominal cavity in females, with normal-sized ovaries, and no origin assigned definitively by intraoperative evaluation. To elucidate the characteristics of NOCS arising from ovarian carcinoma, we investigated the immunohistochemical reactivities of keratin, epithelial membrane antigen(EMA), vimentin, and proliferative cell nuclear antigen(PCNA) in 4 cases of ovarian carcinoma with NOCS(NOCS group), including 3 cases of serous surface papillary adenocarcinoma(SSPC) and 1 case of small ovarian primary serous papillary adenocarcinoma(SPC). These cases were compared with 3 cases of ovarian carcinoma without NOCS(non-NOCS group), including 3 cases of SPC. Cytological and histological testing of the NOCS and non-NOCS groups showed the same findings. Similar reactivities for keratin, EMA and vimentin were observed in the NOCS and non-NOCS groups. No significant change of PCNA labeling index between the groups was seen. However, clinical stage of the NOCS group was higher than that of non-NOCS group. It was hypothesized that exposure of cancer cells to peritoneal cavity in ovarian SSPC leads to the spread. In NOCS case arising from small-sized ovarian carcinoma, another factor was thought to be involved, such as genetic alteration, but it is not known.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11215487

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  1 in total

1.  Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.

Authors:  E Sun Paik; Ji Hye Kim; Tae Joong Kim; Jeong Won Lee; Byoung Gie Kim; Duk Soo Bae; Chel Hun Choi
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.